Full text
PDF![177](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87b1/2073978/f3d3bd3690c6/brjcancer00382-0203.png)
![178](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87b1/2073978/8d575c01765f/brjcancer00382-0204.png)
![179](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87b1/2073978/b7abe4238d60/brjcancer00382-0205.png)
![180](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87b1/2073978/dc723d2991a7/brjcancer00382-0206.png)
![181](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87b1/2073978/27484c456099/brjcancer00382-0207.png)
![182](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87b1/2073978/8da241f3fe26/brjcancer00382-0208.png)
![183](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87b1/2073978/cbc095be936f/brjcancer00382-0209.png)
![184](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87b1/2073978/9e2ff70abbb0/brjcancer00382-0210.png)
![185](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87b1/2073978/7c12f962f9c1/brjcancer00382-0211.png)
![186](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87b1/2073978/e25e3b2e8490/brjcancer00382-0212.png)
![187](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87b1/2073978/399e34b5bf3a/brjcancer00382-0213.png)
![188](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87b1/2073978/cfe00a1acd21/brjcancer00382-0214.png)
![189](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87b1/2073978/efbf80428e44/brjcancer00382-0215.png)
![190](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87b1/2073978/b2128567b41e/brjcancer00382-0216.png)
![191](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87b1/2073978/460c4684c235/brjcancer00382-0217.png)
![192](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87b1/2073978/7a1002be71f7/brjcancer00382-0218.png)
![193](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87b1/2073978/4df810bb3c8c/brjcancer00382-0219.png)
![194](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87b1/2073978/b9741ea068bf/brjcancer00382-0220.png)
![195](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87b1/2073978/d81d2bcaf215/brjcancer00382-0221.png)
![196](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87b1/2073978/565c70ae59d2/brjcancer00382-0222.png)
![197](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87b1/2073978/472f450f812a/brjcancer00382-0223.png)
![198](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87b1/2073978/e421187fb356/brjcancer00382-0224.png)
![199](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87b1/2073978/3d0354432e90/brjcancer00382-0225.png)
![200](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87b1/2073978/2ce3249159e5/brjcancer00382-0226.png)
![201](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87b1/2073978/80ebd64dc68f/brjcancer00382-0227.png)
![202](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87b1/2073978/bb1e7280b761/brjcancer00382-0228.png)
![203](https://cdn.ncbi.nlm.nih.gov/pmc/blobs/87b1/2073978/43d9be8453ca/brjcancer00382-0229.png)
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- BADGER G. M. Chemical constitution and carcinogenic activity. Adv Cancer Res. 1954;2:73–127. doi: 10.1016/s0065-230x(08)60492-3. [DOI] [PubMed] [Google Scholar]
- BERENBLUM I. The effect of podophyllotoxin on the skin of the mouse, with reference to carcinogenic, cocarcinogenic, and anticarcinogenic action. J Natl Cancer Inst. 1951 Feb;11(4):839–841. [PubMed] [Google Scholar]
- BOYLAND E. Chemotherapy of cancer and leucaemias. Oncologia. 1954;7(2):144–154. doi: 10.1159/000223721. [DOI] [PubMed] [Google Scholar]
- Engstrom R. M., Kirschbaum A., Mixer H. W. Effect of Urethane on Mouse Myelogeno us Leukemia. Science. 1947 Mar 7;105(2723):255–256. doi: 10.1126/science.105.2723.255. [DOI] [PubMed] [Google Scholar]
- GALTON D. A. Myleran in chronic myeloid leukaemia; results of treatment. Lancet. 1953 Jan 31;264(6753):208–213. doi: 10.1016/s0140-6736(53)90885-x. [DOI] [PubMed] [Google Scholar]
- GELLHORN A. A critical evaluation of the current status of clinical cancer chemotherapy. Cancer Res. 1953 Mar;13(3):205–215. [PubMed] [Google Scholar]
- GRAFFI A. Uber den Mechanismus der Geschwulstbildung. Schweiz Med Wochenschr. 1953 Sep 12;83(37):865–872. [PubMed] [Google Scholar]
- GWYNN R. H., SALAMAN M. H. Studies on co-carcinogenesis. SH-reactors and other substances tested for co-carcinogenic action in mouse skin. Br J Cancer. 1953 Dec;7(4):482–489. doi: 10.1038/bjc.1953.50. [DOI] [PMC free article] [PubMed] [Google Scholar]
- HENDRY J. A., HOMER R. F., ROSE F. L., WALPOLE A. L. Cytotoxic agents: III, derivatives of ethyleneimine. Br J Pharmacol Chemother. 1951 Sep;6(3):357–410. doi: 10.1111/j.1476-5381.1951.tb00650.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- HILL W. T., STANGER D. W., PIZZO A., RIEGEL B., SHUBIK P., WARTMAN W. B. Inhibition of 9,10-dimethyl-1,2-benzanthracene skin carcinogenesis in mice by polycyclic hydrocarbons. Cancer Res. 1951 Nov;11(11):892–897. [PubMed] [Google Scholar]
- Kennaway E. L. Further experiments on cancer-producing substances. Biochem J. 1930;24(2):497–504. doi: 10.1042/bj0240497. [DOI] [PMC free article] [PubMed] [Google Scholar]
- King M. L., Sullivan M. M. The Similarity of the Effect of Podophyllin and Colchicine and Their Use in the Treatment of Condylomata Acuminata. Science. 1946 Sep 13;104(2698):244–245. doi: 10.1126/science.104.2698.244. [DOI] [PubMed] [Google Scholar]
- LASNITZKI I. Some effects of urethane on the growth and mitosis of normal and malignant cells in vitro. Br J Cancer. 1949 Dec;3(4):501-9, 4 pl. doi: 10.1038/bjc.1949.53. [DOI] [PMC free article] [PubMed] [Google Scholar]
- LOVELESS A., REVELL S. New evidence on the mode of action of mitotic poisons. Nature. 1949 Dec 3;164(4179):938–944. doi: 10.1038/164938a0. [DOI] [PubMed] [Google Scholar]
- Michaelis M., Quastel J. H. The site of action of narcotics in respiratory processes. Biochem J. 1941 Apr;35(4):518–533. doi: 10.1042/bj0350518. [DOI] [PMC free article] [PubMed] [Google Scholar]
- NARPOZZI A. Sull'azione cancerigena dell'azoiprite; ricerche sperimentali. Riv Anat Patol Oncol. 1953 May;6(8):1155–1170. [PubMed] [Google Scholar]
- PETRAKIS N. L., BIERMAN H. R., KELLY K. H., WHITE L. P., SHIMKIN M. B. The effect of 1,4-dimethanesulfonyloxybutane (GT-41 or myleran) upon leukemia. Cancer. 1954 Mar;7(2):383–390. doi: 10.1002/1097-0142(195403)7:2<383::aid-cncr2820070225>3.0.co;2-v. [DOI] [PubMed] [Google Scholar]
- Quastel J. H., Wheatley A. H. Narcotics and brain oxidations. Reversibility of narcotic action in vitro. Biochem J. 1934;28(4):1521–1529. doi: 10.1042/bj0281521. [DOI] [PMC free article] [PubMed] [Google Scholar]
- ROE F. J., SALAMAN M. H. A quantitative study of the power and persistence of the tumour-initiating effect of ethyl carbamate (urethane) on mouse skin. Br J Cancer. 1954 Dec;8(4):666–676. doi: 10.1038/bjc.1954.72. [DOI] [PMC free article] [PubMed] [Google Scholar]
- SALAMAN M. H., GWYNN R. H. The histology of co-carcinogenesis in mouse skin. Br J Cancer. 1951 Jun;5(2):252–263. doi: 10.1038/bjc.1951.26. [DOI] [PMC free article] [PubMed] [Google Scholar]
- SMITH H. H., SRB A. M. Induction of mutations with beta-propiolactone. Science. 1951 Nov 9;114(2967):490–492. doi: 10.1126/science.114.2967.490. [DOI] [PubMed] [Google Scholar]
- Stedman E., Stedman E. Studies on the relationship between chemical constitution and physiological action: The inhibitory action of certain synthetic urethanes on the activity of esterases. Biochem J. 1932;26(4):1214–1222. doi: 10.1042/bj0261214. [DOI] [PMC free article] [PubMed] [Google Scholar]
- WALPOLE A. L., ROBERTS D. C., ROSE F. L., HENDRY J. A., HOMER R. F. Cytotoxic agents. IV. The carcinogenic actions of some monofunctional ethyleneimine derivatives. Br J Pharmacol Chemother. 1954 Sep;9(3):306–323. doi: 10.1111/j.1476-5381.1954.tb01686.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- WILKINSON J. F., HADDOW A., NABARRO J. D. Discussion on the chemotherapy of the reticuloses. Proc R Soc Med. 1953 Sep;46(9):685–700. [PMC free article] [PubMed] [Google Scholar]